Given the broad spectrum of protective effects, irisin is increasingly recognized as a promising therapeutic target for neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, as well as acute cerebrovascular insults like stroke and intracerebral hemorrhage. Here, FNDC5 is linked to stroke disorder.